IL17A and cancer: Furthermore, overexpression of IL-17A and infiltration of macrophages leads to decreased OS (Fig. 3E), suggesting that both are closely related to the prognosis in BRAC patients from the TCGA (The Cancer Genome Atlas Program; https://www.cancer.gov/ccg/) data in TIMER (Tumor IMmune Estimation Resource, https://cistrome.shinyapps.io/timer/).